- Home
- AGI vs HOLX Comparison
AGI vs HOLX Comparison
Compare AGI & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGI
- HOLX
- Stock Information
- Founded
- AGI 2003
- HOLX 1985
- Country
- AGI Canada
- HOLX United States
- Employees
- AGI N/A
- HOLX N/A
- Industry
- AGI Precious Metals
- HOLX Medical Electronics
- Sector
- AGI Basic Materials
- HOLX Health Care
- Exchange
- AGI Nasdaq
- HOLX Nasdaq
- Market Cap
- AGI 14.8B
- HOLX 16.5B
- IPO Year
- AGI 1999
- HOLX 1990
- Fundamental
- Price
- AGI $33.87
- HOLX $74.61
- Analyst Decision
- AGI Strong Buy
- HOLX Hold
- Analyst Count
- AGI 3
- HOLX 15
- Target Price
- AGI $41.00
- HOLX $79.64
- AVG Volume (30 Days)
- AGI 4.3M
- HOLX 5.0M
- Earning Date
- AGI 10-29-2025
- HOLX 11-03-2025
- Dividend Yield
- AGI 0.31%
- HOLX N/A
- EPS Growth
- AGI 112.89
- HOLX N/A
- EPS
- AGI 1.28
- HOLX 2.49
- Revenue
- AGI $1,609,300,000.00
- HOLX $4,100,500,000.00
- Revenue This Year
- AGI $39.28
- HOLX $6.23
- Revenue Next Year
- AGI $27.13
- HOLX $5.37
- P/E Ratio
- AGI $25.55
- HOLX $29.96
- Revenue Growth
- AGI 31.30
- HOLX 1.74
- 52 Week Low
- AGI $17.43
- HOLX $51.90
- 52 Week High
- AGI $37.54
- HOLX $80.31
- Technical
- Relative Strength Index (RSI)
- AGI 57.39
- HOLX 72.69
- Support Level
- AGI $30.21
- HOLX $74.07
- Resistance Level
- AGI $31.62
- HOLX $74.28
- Average True Range (ATR)
- AGI 1.17
- HOLX 0.23
- MACD
- AGI 0.19
- HOLX -0.12
- Stochastic Oscillator
- AGI 97.63
- HOLX 96.91
About AGI Alamos Gold Inc.
Alamos Gold Inc acquires, explores, and produces gold and other precious metals, and operates in two principal geographic areas: Canada and Mexico. The company has four operating segments being Young-Davidson, Island Gold and Magino mines operate in Canada, and the Mulatos mine operates in Sonora, Mexico. The company generates maximum revenue from the Mulatos mines.
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.